Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Macek (Praha, Czech Republic). The changing epidemiology of CF. International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission

Member's Comments

No comment yet.

Related content which might interest you: NTM: an overview of changing epidemiology Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment Year: 2021 Paediatric respiratory epidemiology: asthma phenotypes – do they exist? Source: Annual Congress 2009 - Paediatric year in review Year: 2009 Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014 What can we learn about pulmonary infection from studying the microbiome in CF? Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research? Year: 2016 Challenges in understanding host genetics and severity of community-acquired pneumonia Source: ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020 Year: 2021 Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions Source: Eur Respir J 2016; 48: 1545-1548 Year: 2016 Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs Year: 2018 CF microbiology, emerging pathogens and more treatment options Source: Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults Year: 2013 Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country Source: ERJ Open Res, 5 (4) 00110-2018; 10.1183/23120541.00110-2018 Year: 2019 The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 Knowledge of the general population about COPD and its determinants: Current status and recent changes in Spain Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012